Systemic Antiviral Pharmaceuticals Market Systemic Antiviral Pharmaceuticals Market Research

Systemic Antiviral Pharmaceuticals Market Research Report : forecast 2023
Global Systemic Antiviral Pharmaceuticals Market
Antiviral drugs are a class of medication that inhibits the development of infection causing viruses.
Like antibiotics, specific antiviral drugs are used against specific viruses. As viruses share most of
the metabolic processes with the host cell, it is difficult to commercialize new medications that are
selective in action. The presently available antiviral agents either act as DNA polymerase inhibitors,
reverse transcriptase inhibitors, protease inhibitors, immunomodulators, neuraminidase inhibitors or
integrase strand transfer inhibitors. The currently available antiviral drugs target four main kinds of
viruses:
Herpes
Hepatitis
Influenza
Human Immunodeficiency Virus (HIV)
Global Systemic Antiviral Pharmaceuticals Market: Segmentation
Antiviral drugs can be administered by various methods such as topical or local application, systemic
delivery, controlled delivery and targeted delivery. Systemic drug delivery is relatively safe and
effective for the treatment than topical agents. In recent times, systemic delivery method is gaining
attention owing to its higher therapeutic efficacy and bioavailability. The demand for products with
systemic application is high especially in the treatment for chronic viral infections such as hepatitis
and HIV infection.
Based on the class of antiviral drugs, the global systemic antiviral pharmaceuticals market is
segmented into DNA polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors,
immunomodulators, interferon, neuraminidase inhibitors and integrase strand transfer inhibitors.
Increasing resistance to M2 inhibitors has shifted the focus towards neuraminidase inhibitors for the
treatment of influenza. Neuraminidase inhibitors class of drugs includes Oseltamivir and Zanamivir
which are administered through systemic route. Herpes virus can be treated using medications such
as Acyclovir, Brivudin, Cidofovir, Famciclovir, Fomivirsen, Foscarnet, Ganciclovir, Penciclovir,
Valacyclovir, Vidarabine and Valganciclovir. Treatment for hepatitis includes administration of either
or combination of the following medications:
Interferons
Ribavarin
Nucleoside analogues such as Adefovir, Emtricitabine, Entecavir, Lamivudine, Telbivudine and